Correlations between serum and AT sex steroid concentrations and parameters of adiposity
. | BMI . | Waist circumference . | BAI . |
---|---|---|---|
HT−, n = 8-13 | |||
Serum E1 | 0.52 | 0.48 | 0.64a |
Serum E2 | 0.60a | 0.51 | 0.63a |
Serum free E2 | 0.64a | 0.55 | 0.65a |
Serum E1S | 0.33 | 0.41 | 0.56a |
E1 sc | 0.62a | 0.65a | 0.69b |
E1 visc | 0.80c | 0.72b | 0.65a |
E1 + E2/T + A4 sc | 0.23 | 0.45 | 0.62a |
E1 + E2/T + A4 visc | 0.51 | 0.17 | 0.70a |
HT±, n = 19-48 | |||
Serum E1 | −0.35b | −0.23 | −0.36b |
Serum E2 | −0.22 | −0.10 | −0.29 |
Serum free E2 | −0.14 | −0.06 | −0.22 |
Serum E1S | −0.41b | −0.34a | −0.37a |
E1 sc | −0.17 | 0.08 | −0.13 |
E1 visc | −0.33a | −0.24 | −0.39a |
E1 + E2/T + A4 sc | 0.04 | 0.23 | −0.10 |
E1 + E2/T + A4 visc | −0.13 | −0.03 | −0.21 |
. | BMI . | Waist circumference . | BAI . |
---|---|---|---|
HT−, n = 8-13 | |||
Serum E1 | 0.52 | 0.48 | 0.64a |
Serum E2 | 0.60a | 0.51 | 0.63a |
Serum free E2 | 0.64a | 0.55 | 0.65a |
Serum E1S | 0.33 | 0.41 | 0.56a |
E1 sc | 0.62a | 0.65a | 0.69b |
E1 visc | 0.80c | 0.72b | 0.65a |
E1 + E2/T + A4 sc | 0.23 | 0.45 | 0.62a |
E1 + E2/T + A4 visc | 0.51 | 0.17 | 0.70a |
HT±, n = 19-48 | |||
Serum E1 | −0.35b | −0.23 | −0.36b |
Serum E2 | −0.22 | −0.10 | −0.29 |
Serum free E2 | −0.14 | −0.06 | −0.22 |
Serum E1S | −0.41b | −0.34a | −0.37a |
E1 sc | −0.17 | 0.08 | −0.13 |
E1 visc | −0.33a | −0.24 | −0.39a |
E1 + E2/T + A4 sc | 0.04 | 0.23 | −0.10 |
E1 + E2/T + A4 visc | −0.13 | −0.03 | −0.21 |
Data are presented as Spearman correlation coefficient. Boldface indicates statistically significant correlation coefficients.
Abbreviations: A4, androstenedione; BAI, body adiposity index; BMI, body mass index; E1, estrone; E2, estradiol; E1S, estrone sulfate; Sc, subcutaneous adipose tissue; T, testosterone; Visc, visceral adipose tissue.
aP < .05.
bP ≤ .01.
cP ≤ .001.
Correlations between serum and AT sex steroid concentrations and parameters of adiposity
. | BMI . | Waist circumference . | BAI . |
---|---|---|---|
HT−, n = 8-13 | |||
Serum E1 | 0.52 | 0.48 | 0.64a |
Serum E2 | 0.60a | 0.51 | 0.63a |
Serum free E2 | 0.64a | 0.55 | 0.65a |
Serum E1S | 0.33 | 0.41 | 0.56a |
E1 sc | 0.62a | 0.65a | 0.69b |
E1 visc | 0.80c | 0.72b | 0.65a |
E1 + E2/T + A4 sc | 0.23 | 0.45 | 0.62a |
E1 + E2/T + A4 visc | 0.51 | 0.17 | 0.70a |
HT±, n = 19-48 | |||
Serum E1 | −0.35b | −0.23 | −0.36b |
Serum E2 | −0.22 | −0.10 | −0.29 |
Serum free E2 | −0.14 | −0.06 | −0.22 |
Serum E1S | −0.41b | −0.34a | −0.37a |
E1 sc | −0.17 | 0.08 | −0.13 |
E1 visc | −0.33a | −0.24 | −0.39a |
E1 + E2/T + A4 sc | 0.04 | 0.23 | −0.10 |
E1 + E2/T + A4 visc | −0.13 | −0.03 | −0.21 |
. | BMI . | Waist circumference . | BAI . |
---|---|---|---|
HT−, n = 8-13 | |||
Serum E1 | 0.52 | 0.48 | 0.64a |
Serum E2 | 0.60a | 0.51 | 0.63a |
Serum free E2 | 0.64a | 0.55 | 0.65a |
Serum E1S | 0.33 | 0.41 | 0.56a |
E1 sc | 0.62a | 0.65a | 0.69b |
E1 visc | 0.80c | 0.72b | 0.65a |
E1 + E2/T + A4 sc | 0.23 | 0.45 | 0.62a |
E1 + E2/T + A4 visc | 0.51 | 0.17 | 0.70a |
HT±, n = 19-48 | |||
Serum E1 | −0.35b | −0.23 | −0.36b |
Serum E2 | −0.22 | −0.10 | −0.29 |
Serum free E2 | −0.14 | −0.06 | −0.22 |
Serum E1S | −0.41b | −0.34a | −0.37a |
E1 sc | −0.17 | 0.08 | −0.13 |
E1 visc | −0.33a | −0.24 | −0.39a |
E1 + E2/T + A4 sc | 0.04 | 0.23 | −0.10 |
E1 + E2/T + A4 visc | −0.13 | −0.03 | −0.21 |
Data are presented as Spearman correlation coefficient. Boldface indicates statistically significant correlation coefficients.
Abbreviations: A4, androstenedione; BAI, body adiposity index; BMI, body mass index; E1, estrone; E2, estradiol; E1S, estrone sulfate; Sc, subcutaneous adipose tissue; T, testosterone; Visc, visceral adipose tissue.
aP < .05.
bP ≤ .01.
cP ≤ .001.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.